Porcine Epidemic Diarrhea Virus nucleoprotein antibody and antigen (recombinant protein)

 Download 

Diagnostic anti-Porcine Epidemic Diarrhea Virus nucleoprotein antibodies pairs and antigen for animal health (animal Swine/Porcine/Pig infectious disease Porcine epidemic diarrhea) testing in ELISA, colloidal gold-based Lateral flow immunoassay (LFIA), CLIA, TINIA and POCT

Go to Swine/Porcine/Pig disease testing products collection >>

Product information

Catalog No.	Description	US $ Price (per mg)
GMP-VT-P108-Tg001-Ag01	Recombinant Porcine Epidemic Diarrhea Virus nucleoprotein protein	$3090.00
GMP-VT-P108-Tg001-Ab01	Anti-Porcine Epidemic Diarrhea Virus nucleoprotein mouse monoclonal antibody (mAb)	$3090.00
GMP-VT-P108-Tg001-Ab02	Anti-Porcine Epidemic Diarrhea Virus nucleoprotein mouse monoclonal antibody (mAb)	$3090.00
GMP-VT-P108-Tg001-Ab03	Anti-Porcine Epidemic Diarrhea Virus nucleoprotein human monoclonal antibody (mAb)	$3090.00
GMP-VT-P108-Tg001-Ab04	Anti-Porcine Epidemic Diarrhea Virus nucleoprotein human monoclonal antibody (mAb)	$3090.00

Size： 1mg | 10mg | 100mg

Product Description

Cat No.	GMP-VT-P108-Tg001-Ag01
Product Name	Recombinant Porcine Epidemic Diarrhea Virus nucleoprotein protein
Pathogen	Porcine Epidemic Diarrhea Virus
Expression platform	E.coli
Isotypes	Recombinant Antigen
Bioactivity validation	Anti-Porcine Epidemic Diarrhea Virus nucleoprotein antibodies binding, Immunogen in Sandwich Elisa, lateral-flow tests, and other immunoassays as control material in Porcine Epidemic Diarrhea Virus level test of animal Swine/Porcine/Pig infectious disease with Porcine epidemic diarrhea.
Tag	His
Product description	Recombinant Porcine Epidemic Diarrhea Virus nucleoprotein proteinwas expressed in E.coli - based prokaryotic cell expression system and is expressed with 6 HIS tag at the C-terminus.
Purity	Purity: ≥95% (SDS-PAGE)
Application	Paired antibody immunoassay validation in sandwich Elisa, ELISA, colloidal gold-based Lateral flow immunoassay (LFIA), CLIA, TINIA, POCT and other immunoassays.
Formulation	Lyophilized from sterile PBS, PH 7.4
Storage	Store at -20℃ to -80℃ under sterile conditions. Avoid repeated freeze-thaw cycles.

Cat No.	GMP-VT-P108-Tg001-Ab01,GMP-VT-P108-Tg001-Ab02
Pathogen	Porcine Epidemic Diarrhea Virus
Product Name	Anti-Porcine Epidemic Diarrhea Virus nucleoprotein mouse monoclonal antibody (mAb)
Expression platform	CHO
Isotypes	Mouse IgG
Bioactivity validation	Recombinant Porcine Epidemic Diarrhea Virus nucleoprotein antigen binding, ELISA validated as capture antibody and detection antibody. Pair recommendation with other anti-Porcine Epidemic Diarrhea Virus antibodies in Porcine Epidemic Diarrhea Virus level test of animal Swine/Porcine/Pig infectious disease with Porcine epidemic diarrhea.
Product description	Anti-Porcine Epidemic Diarrhea Virus nucleoprotein mouse monoclonal antibody (mAb) is a mouse monoclonal antibody produced by CHO technology. The antibody is ELISA validated as capture antibody and detection antibody. Pair recommendation with other anti-Porcine Epidemic Diarrhea Virus antibodies.
Purity	Purity: ≥95% (SDS-PAGE)
Application	Paired antibody immunoassay validation in sandwich Elisa, ELISA, colloidal gold-based Lateral flow immunoassay (LFIA), CLIA, TINIA, POCT and other immunoassays.
Formulation	Lyophilized from sterile PBS, PH 7.4
Storage	Store at -20℃ to -80℃ under sterile conditions. Avoid repeated freeze-thaw cycles.

Cat No.	GMP-VT-P108-Tg001-Ab03,GMP-VT-P108-Tg001-Ab04
Pathogen	Porcine Epidemic Diarrhea Virus
Product Name	Anti-Porcine Epidemic Diarrhea Virus nucleoprotein human monoclonal antibody (mAb)
Expression platform	CHO
Isotypes	Human lgG1
Bioactivity validation	Recombinant Porcine Epidemic Diarrhea Virus nucleoprotein antigen binding, ELISA validated as capture antibody and detection antibody. Pair recommendation with other anti-Porcine Epidemic Diarrhea Virus antibodies in Porcine Epidemic Diarrhea Virus level test of animal Swine/Porcine/Pig infectious disease with Porcine epidemic diarrhea.
Product description	Anti-Porcine Epidemic Diarrhea Virus nucleoprotein mouse monoclonal antibody (mAb) is a human monoclonal antibody produced by CHO. The antibody is ELISA validated as capture antibody and detection antibody pair.
Purity	Purity: ≥95% (SDS-PAGE)
Application	Paired antibody immunoassay validation in sandwich Elisa, ELISA, colloidal gold-based Lateral flow immunoassay (LFIA), CLIA, TINIA, POCT and other immunoassays.
Formulation	Lyophilized from sterile PBS, PH 7.4
Storage	Store at -20℃ to -80℃ under sterile conditions. Avoid repeated freeze-thaw cycles.

Reference

Validation Data

Click to get more Data / Case study about the product.

Pathogen Information

Porcine epidemic diarrhea virus (PEDV) is a highly contagious viral disease that affects the digestive system of pigs. The disease was first discovered in the United Kingdom in 1971, and since then, it has spread globally, causing significant economic losses to the pig industry.

PEDV is an enveloped, single-stranded RNA virus classified under the Coronaviridae family. It is a positive-sense RNA virus with a genome size of approximately 28 kilobases. The genome encodes several structural and non-structural proteins necessary for the replication, assembly, and release of the virus.

The PEDV genome is organized into multiple open reading frames (ORFs), including ORF1a/1b, spike (S), membrane (M), envelope (E), and nucleocapsid (N). The ORF1a/1b region encodes two large polyproteins that are cleaved into non-structural proteins, including RNA replicase and helicase. The S protein mediates virus attachment and entry into the host cells, while the M protein is involved in virion assembly and release. The E protein plays a crucial role in virus assembly and pathogenesis, while the N protein is critical for virus replication and packaging.

PEDV primarily infects pigs of all ages, but the most severe cases occur in suckling piglets. The virus causes acute enteritis, leading to severe diarrhea, vomiting, dehydration, and high mortality rates. In neonatal piglets, PEDV infection can cause up to 100% mortality within the first week of life, leading to significant economic losses to the pig industry.

The transmission of PEDV occurs mainly through the fecal-oral route, either through direct or indirect contact with infected pigs, contaminated feed, equipment, or other fomites. The virus can survive in the environment for an extended period, making it challenging to control its spread.

PEDV diagnosis relies on various methods, including virus isolation, antigen and antibody detection, histopathology, and nucleic acid amplification. Virus isolation involves culturing the virus in vitro and identifying the virus using immunofluorescence or electron microscopy. Antigen and antibody detection are based on the detection of viral proteins or virus-specific antibodies in serum or fecal samples. Histopathology involves examining tissue sections for specific pathological changes characteristic of PEDV infection. Nucleic acid amplification techniques, such as RT-PCR, qPCR, and LAMP, are highly sensitive and specific methods for detecting PEDV RNA.

Prevention and control of PEDV involve a combination of measures, including biosecurity, vaccination, and treatment. Biosecurity measures aim to prevent the introduction and spread of the virus by minimizing direct and indirect contact between infected and non-infected animals. Vaccination can reduce the severity and incidence of the disease in infected herds, and treatment involves supportive therapy, including rehydration and electrolyte replacement.

In conclusion, PEDV is a significant threat to the global swine industry due to its high mortality rates and economic impact. The virus is highly contagious and challenging to control, making it essential to take preventive measures through biosecurity and vaccination. Early and accurate diagnosis is crucial for effective control and prevention of PEDV outbreaks.

About GDU